• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于 3D 肿瘤球体形成的自动化高通量筛选(HTS)点样器。

An Automated High-Throughput Screening (HTS) Spotter for 3D Tumor Spheroid Formation.

机构信息

Central R & D Center, Medical & Bio Decision (MBD) Co., Ltd., Suwon-si 16229, Gyeonggi-do, Republic of Korea.

Department of Biomedical Engineering, Gachon University, Seongnam-si 13120, Gyeonggi-do, Republic of Korea.

出版信息

Int J Mol Sci. 2023 Jan 5;24(2):1006. doi: 10.3390/ijms24021006.

DOI:10.3390/ijms24021006
PMID:36674523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9867480/
Abstract

Three-dimensional (3D) culture platforms have been adopted in a high-throughput screening (HTS) system to mimic in vivo physiological microenvironments. The automated dispenser has been established commercially to enable spotting or distributing non-viscous or viscous biomaterials onto microplates. However, there are still challenges to the precise and accurate dispensation of cells embedded in hydrogels such as Alginate- and Matrigel-extracellular matrices. We developed and improved an automated contact-free dispensing machine, the ASFA SPOTTER (V5 and V6), which is compatible with 96- and 384-pillar/well plates and 330- and 532-micropillar/well chips for the support of 3D spheroid/organoid models using bioprinting techniques. This enables the distribution of non-viscous and viscous biosamples, including chemical drugs and cancer cells, for large-scale drug screening at high speed and small volumes (20 to 4000 nanoliters) with no damage to cells. The ASFA SPOTTER (V5 and V6) utilizes a contact-free method that minimizes cross-contamination for the dispensation of encapsulated tissue cells with highly viscous scaffolds (over 70%). In particular, the SPOTTER V6 does not require a washing process and offers the advantage of almost no dead volume (defined as additional required sample volume, including a pre-shot and flushing shot for dispensing). It can be successfully applied for the achievement of an organoid culture in automation, with rapid and easy operation, as well as miniaturization for high-throughput screening. In this study, we report the advantages of the ASFA SPOTTER, which distributes standard-sized cell spots with hydrogels onto a 384-pillar/well plate with a fast dispensing speed, small-scale volume, accuracy, and precision.

摘要

三维(3D)培养平台已被应用于高通量筛选(HTS)系统,以模拟体内生理微环境。自动化分配器已商业化建立,能够将非粘性或粘性生物材料点样或分配到微孔板上。然而,对于嵌入水凝胶(如藻酸盐和基质胶)中的细胞的精确和准确分配仍然存在挑战。我们开发并改进了一种自动化无接触分配机,即 ASFA SPOTTER(V5 和 V6),它与 96 孔和 384 孔/孔板以及 330 孔和 532 微柱/孔芯片兼容,用于支持使用生物打印技术的 3D 球体/类器官模型。这使得非粘性和粘性生物样品(包括化学药物和癌细胞)的分配成为可能,用于高速和小体积(20 至 4000 纳升)的大规模药物筛选,且不会对细胞造成损伤。ASFA SPOTTER(V5 和 V6)利用无接触方法,最大限度地减少了对高粘性支架(超过 70%)包封组织细胞的分配中的交叉污染。特别是,SPOTTER V6 不需要清洗过程,并且具有几乎没有死体积(定义为分配所需的额外样品体积,包括预喷和冲洗喷)的优点。它可以成功地应用于自动化实现类器官培养,具有快速和易于操作的优点,并且适用于高通量筛选的小型化。在本研究中,我们报告了 ASFA SPOTTER 的优势,它可以以快速的分配速度、小体积、准确性和精密度将带有水凝胶的标准尺寸细胞点样分配到 384 孔/孔板上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/7eb371e29c2f/ijms-24-01006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/303015213184/ijms-24-01006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/b231e4854d8c/ijms-24-01006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/7ceed251eacb/ijms-24-01006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/7eb371e29c2f/ijms-24-01006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/303015213184/ijms-24-01006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/b231e4854d8c/ijms-24-01006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/7ceed251eacb/ijms-24-01006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24a/9867480/7eb371e29c2f/ijms-24-01006-g004.jpg

相似文献

1
An Automated High-Throughput Screening (HTS) Spotter for 3D Tumor Spheroid Formation.一种用于 3D 肿瘤球体形成的自动化高通量筛选(HTS)点样器。
Int J Mol Sci. 2023 Jan 5;24(2):1006. doi: 10.3390/ijms24021006.
2
A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis.用于稳健的人类类器官培养和分析的支柱和灌注板平台。
Adv Healthc Mater. 2024 Aug;13(21):e2302502. doi: 10.1002/adhm.202302502. Epub 2023 Sep 10.
3
Recent advances in microarray 3D bioprinting for high-throughput spheroid and tissue culture and analysis.微阵列 3D 生物打印在高通量球体和组织培养及分析方面的最新进展。
Essays Biochem. 2021 Aug 10;65(3):481-489. doi: 10.1042/EBC20200150.
4
Automating a Magnetic 3D Spheroid Model Technology for High-Throughput Screening.自动化磁 3D 球体模型技术以实现高通量筛选。
SLAS Technol. 2019 Aug;24(4):420-428. doi: 10.1177/2472630319854337. Epub 2019 Jun 21.
5
Optimization of 3D-aggregated spheroid model (3D-ASM) for selecting high efficacy drugs.用于筛选高效药物的 3D 聚集球体模型(3D-ASM)的优化。
Sci Rep. 2022 Nov 7;12(1):18937. doi: 10.1038/s41598-022-23474-5.
6
High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.高通量器官柱上(high-TOP)阵列系统用于三维离体药物测试。
Biomaterials. 2023 May;296:122087. doi: 10.1016/j.biomaterials.2023.122087. Epub 2023 Mar 7.
7
Tissue-Engineered 3D In Vitro Disease Models for High-Throughput Drug Screening.用于高通量药物筛选的组织工程化 3D 体外疾病模型。
Tissue Eng Regen Med. 2023 Jul;20(4):523-538. doi: 10.1007/s13770-023-00522-3. Epub 2023 Mar 9.
8
Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.开发微型 3D 类器官培养平台,用于超高通量筛选。
J Mol Cell Biol. 2020 Aug 1;12(8):630-643. doi: 10.1093/jmcb/mjaa036.
9
A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis.用于强大的人类类器官培养与分析的柱形和灌注板平台
bioRxiv. 2023 Mar 13:2023.03.11.532210. doi: 10.1101/2023.03.11.532210.
10
Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture.β-发夹水凝胶作为三维细胞培养中高通量药物发现的支架。
Anal Biochem. 2017 Oct 15;535:25-34. doi: 10.1016/j.ab.2017.07.024. Epub 2017 Jul 27.

引用本文的文献

1
High-throughput non-homogenous 3D polycaprolactone scaffold for cancer cell and cancer-associated fibroblast mini-tumors to evaluate drug treatment response.用于癌细胞和癌症相关成纤维细胞微肿瘤以评估药物治疗反应的高通量非均质3D聚己内酯支架
Toxicol Rep. 2024 Dec 12;14:101863. doi: 10.1016/j.toxrep.2024.101863. eCollection 2025 Jun.
2
Advancing cancer research through organoid technology.通过类器官技术推进癌症研究。
J Transl Med. 2024 Nov 8;22(1):1007. doi: 10.1186/s12967-024-05824-1.
3
Brain organoid as a model to study the role of mitochondria in neurodevelopmental disorders: achievements and weaknesses.

本文引用的文献

1
Optimization of 3D-aggregated spheroid model (3D-ASM) for selecting high efficacy drugs.用于筛选高效药物的 3D 聚集球体模型(3D-ASM)的优化。
Sci Rep. 2022 Nov 7;12(1):18937. doi: 10.1038/s41598-022-23474-5.
2
A novel 3D pillar/well array platform using patient-derived head and neck tumor to predict the individual radioresponse.一种使用患者来源的头颈部肿瘤来预测个体放射反应的新型三维柱状/孔阵列平台。
Transl Oncol. 2022 Oct;24:101483. doi: 10.1016/j.tranon.2022.101483. Epub 2022 Jul 16.
3
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
脑类器官作为研究线粒体在神经发育障碍中作用的模型:成就与不足
Front Cell Neurosci. 2024 Jun 24;18:1403734. doi: 10.3389/fncel.2024.1403734. eCollection 2024.
4
Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion.利用恶性胸腔积液预测表皮生长因子受体(EGFR)突变型肺癌患者来源类器官的酪氨酸激酶抑制剂(TKI)反应
NPJ Precis Oncol. 2024 May 21;8(1):111. doi: 10.1038/s41698-024-00609-7.
患者来源的肿瘤类器官的临床转化——瓶颈与策略
Biomark Res. 2022 Mar 10;10(1):10. doi: 10.1186/s40364-022-00356-6.
4
High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.高通量 3D 肿瘤球体阵列平台用于评估质子药物组合的敏感性。
Int J Mol Sci. 2022 Jan 6;23(2):587. doi: 10.3390/ijms23020587.
5
Developments and Opportunities for 3D Bioprinted Organoids.3D生物打印类器官的发展与机遇
Int J Bioprint. 2021 Jun 28;7(3):364. doi: 10.18063/ijb.v7i3.364. eCollection 2021.
6
High-Throughput Screening of Compound Neurotoxicity Using 3D-Cultured Neural Stem Cells on a 384-Pillar Plate.使用384柱板上的3D培养神经干细胞进行化合物神经毒性的高通量筛选
Curr Protoc. 2021 Apr;1(4):e107. doi: 10.1002/cpz1.107.
7
Patient-derived organoid (PDO) platforms to facilitate clinical decision making.源自患者的类器官(PDO)平台助力临床决策。
J Transl Med. 2021 Jan 21;19(1):40. doi: 10.1186/s12967-020-02677-2.
8
Nanoliter Centrifugal Liquid Dispenser Coupled with Superhydrophobic Microwell Array Chips for High-Throughput Cell Assays.用于高通量细胞分析的纳升离心式液体分配器与超疏水微孔阵列芯片联用
Micromachines (Basel). 2018 Jun 6;9(6):286. doi: 10.3390/mi9060286.
9
Automating drug discovery.自动化药物发现。
Nat Rev Drug Discov. 2018 Feb;17(2):97-113. doi: 10.1038/nrd.2017.232. Epub 2017 Dec 15.
10
Concise Review: Bioprinting of Stem Cells for Transplantable Tissue Fabrication.简明综述:用于可移植组织制造的干细胞的生物打印。
Stem Cells Transl Med. 2017 Oct;6(10):1940-1948. doi: 10.1002/sctm.17-0148. Epub 2017 Aug 24.